133 related articles for article (PubMed ID: 7323688)
21. Antibodies to SS-A/Ro-52kD and centromere in autoimmune liver disease: a clue to diagnosis and prognosis of primary biliary cirrhosis.
Granito A; Muratori P; Muratori L; Pappas G; Cassani F; Worthington J; Ferri S; Quarneti C; Cipriano V; de Molo C; Lenzi M; Chapman RW; Bianchi FB
Aliment Pharmacol Ther; 2007 Sep; 26(6):831-8. PubMed ID: 17767467
[TBL] [Abstract][Full Text] [Related]
22. Profiles of antinuclear antibodies in chronic active hepatitis, primary biliary cirrhosis and alcoholic liver disease.
Kurki P; Gripenberg M; Teppo AM; Salaspuro M
Liver; 1984 Apr; 4(2):134-8. PubMed ID: 6610088
[TBL] [Abstract][Full Text] [Related]
23. Anti-idiotypic antibodies to anti-PDC-E2 in primary biliary cirrhosis and normal subjects.
Chen QY; Rowley MJ; Mackay IR
Hepatology; 1999 Mar; 29(3):624-31. PubMed ID: 10051459
[TBL] [Abstract][Full Text] [Related]
24. Neutrophil phagocytic and bactericidal function in primary biliary cirrhosis and other chronic liver diseases.
De Fernandez MA; Clark A; Triger DR
Clin Exp Immunol; 1987 Mar; 67(3):655-61. PubMed ID: 3608234
[TBL] [Abstract][Full Text] [Related]
25. Cryoglobulins in primary biliary cirrhosis: prevalence and modulation by immunosuppressive therapy.
Taal BG; Schalm SW
Z Gastroenterol; 1985 May; 23(5):228-34. PubMed ID: 3909671
[TBL] [Abstract][Full Text] [Related]
26. Profiles of serum complement in patients with hepatobiliary diseases.
Potter BJ; Elias E; Fayers PM; Jones EA
Digestion; 1978; 18(5-6):371-83. PubMed ID: 86474
[TBL] [Abstract][Full Text] [Related]
27. IgA antibody to lipid A in alcoholic liver disease.
Nolan JP; DeLissio MG; Camara DS; Feind DM; Gagliardi NC
Lancet; 1986 Jan; 1(8474):176-9. PubMed ID: 2868205
[TBL] [Abstract][Full Text] [Related]
28. IgM in primary biliary cirrhosis. Physicochemical and complement activating properties.
Lindgren S; Eriksson S
J Lab Clin Med; 1982 May; 99(5):636-45. PubMed ID: 7069268
[TBL] [Abstract][Full Text] [Related]
29. Interleukin 2 activity in chronic liver disease and the effect of in vitro alpha-interferon.
Saxena S; Nouri-Aria KT; Anderson MG; Eddleston AL; Williams R
Clin Exp Immunol; 1986 Mar; 63(3):541-8. PubMed ID: 3486732
[TBL] [Abstract][Full Text] [Related]
30. Immunostaining of plasma cells in primary biliary cirrhosis.
Daniels JA; Torbenson M; Anders RA; Boitnott JK
Am J Clin Pathol; 2009 Feb; 131(2):243-9. PubMed ID: 19141384
[TBL] [Abstract][Full Text] [Related]
31. [Immunological characteristics of primary biliary cirrhosis patients].
Yan HP; Zhuang H; Liu YM; Feng X; Tan YF; Liu Y; Zhang X; Zhao CH
Zhonghua Gan Zang Bing Za Zhi; 2005 Jan; 13(1):12-6. PubMed ID: 15670483
[TBL] [Abstract][Full Text] [Related]
32. Detection of circulating immune complexes in alcoholic liver disease.
Penner E; Albini B; Milgrom F
Clin Exp Immunol; 1978 Oct; 34(1):28-31. PubMed ID: 373931
[TBL] [Abstract][Full Text] [Related]
33. Immunoglobulin and complement depositions in the liver of chronic hepatitis patients.
Vasei M; Monabbati A; Alizadeh-Naeeni M; Houshmand S; Azarpira N; Lankarani KB; Mosallaee M; Taghavi Sa; Geramizadeh B; Saberi-Firouzi M; Imaniyeh MH
Hepatogastroenterology; 2008; 55(84):1066-70. PubMed ID: 18705329
[TBL] [Abstract][Full Text] [Related]
34. Impaired opsonization by serum from patients with chronic liver disease.
Wyke RJ; Rajkovic IA; Williams R
Clin Exp Immunol; 1983 Jan; 51(1):91-8. PubMed ID: 6339126
[TBL] [Abstract][Full Text] [Related]
35. [Immunological indices in chronic liver diseases].
Maleev A; Krustev Z; Ognianov M; Kolarski V; Ninova D
Vutr Boles; 1977; 16(3):33-8. PubMed ID: 898922
[TBL] [Abstract][Full Text] [Related]
36. Etiologies of chronic liver diseases in Hong Kong.
Fung KT; Fung J; Lai CL; Yuen MF
Eur J Gastroenterol Hepatol; 2007 Aug; 19(8):659-64. PubMed ID: 17625435
[TBL] [Abstract][Full Text] [Related]
37. The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis.
Tanaka A; Nezu S; Uegaki S; Mikami M; Okuyama S; Kawamura N; Aiso M; Gershwin ME; Takahashi S; Selmi C; Takikawa H
Ann N Y Acad Sci; 2007 Jun; 1107():259-70. PubMed ID: 17804554
[TBL] [Abstract][Full Text] [Related]
38. Circulating complement fixing immune complexes in chronic hepatitis. Use of anti-C3 enzyme immunoassay to define antibody class and nature of antigen.
Sagnelli E; Felaco FM; Triolo G; Vernace SJ; Filippini P; Piccinino F; Behrens U; Paronetto F
J Clin Lab Immunol; 1983 Sep; 12(1):11-5. PubMed ID: 6195340
[TBL] [Abstract][Full Text] [Related]
39. Characterization of bile ducts in primary biliary cirrhosis and other liver diseases by immunohistochemical demonstration of Lewis(a) or b antigen.
Fritz P; Pedal I; Oeffinger B; Tuczek HV; Wagner T; Rühl U; Romen A; Bader H
Zentralbl Pathol; 1994 Nov; 140(4-5):299-307. PubMed ID: 7826978
[TBL] [Abstract][Full Text] [Related]
40. Monomeric (7S) IgM in chronic liver disease.
Fakunle YM; Aranguibel F; de Villiers D; Thomas HC; Sherlock S
Clin Exp Immunol; 1979 Nov; 38(2):204-10. PubMed ID: 118836
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
